Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $685.7000 (1.14%) ($685.7000 - $685.7000) on Thu. Mar. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 78 | Latest Price | $685.7000(1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.7% a day on average for past five trading days. | Weekly Trend | REGN advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(41%) XLV(40%) IWD(39%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -0.755% in a week (0% probabilities). VIXM(-19%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $665.83(2.98%) | 10 Day Moving Average | $644.97(6.32%) | 20 Day Moving Average | $629.79(8.88%) | To recent high | 0% | To recent low | 15.2% | Market Cap | $72.704b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |